Image

Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing

Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing

Recruiting
65 years and older
Male
Phase N/A

Powered by AI

Overview

This protocol describes development and user testing of an educational shared decision making intervention to help men with prostate cancer who are on active surveillance make decisions with their health care providers about if and when to de-escalate surveillance testing. The project is important because for many patients their cancer does not progress to the point of needed curative treatment or their health status changes such that they are no longer good candidates for treatment. For these men, de-escalating ongoing surveillance (e.g., fewer biopsies or imaging studies) is a reasonable option.

Description

Objectives

The overall goal of this protocol is to develop and refine an educational tool for use by patients and health-care providers to help men with localized prostate cancer make informed decisions about discontinuation of active surveillance.

  • Conduct cognitive and initial usability and acceptability testing of a prototype decision aid with patients
  • Conduct cognitive and initial usability and acceptability testing of a prototype decision aid with care partners/caregivers
  • Conduct expert reviews of a prototype decision aid with clinicians

Eligibility

Patients

Inclusion Criteria:

  1. Males aged 65 or older
  2. Diagnosis of localized prostate cancer
  3. On active surveillance for 12 or more months
  4. Fluent in English

Exclusion Criteria:

  1. Receiving treatment for another cancer (primary or recurrence)

Caregivers

Inclusion Criteria:

  1. Aged 18 or older
  2. Fluent in English
  3. Involved with the care of an eligible patient (i.e. partner, close friend, family member, companion)

    Exclusion Criteria:

  4. None

Clinicians

Inclusion Criteria:

  1. Aged 18 or older
  2. Fluent in English
  3. Provides clinical care for patients with prostate cancer (e.g. medical oncologists, urologists, radiation oncologists, nurse practitioners, physician assistants)

Exclusion Criteria:

  1. None

Study details
    Prostate Cancer

NCT05497024

M.D. Anderson Cancer Center

1 November 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.